Posts Tagged ‘Stigma’

Public Service Announcement — Psychiatry Kills!

Monday, November 9th, 2020

Recently, during the Covid-19 pandemic lockdowns, TV has been saturated with advertisements for psychiatric mental health care.

One of the most common is Robin Meade’s “Public Service Announcement” (PSA) hustling for NAMI.

The National Alliance for the Mentally Ill (NAMI) was founded in 1979. It has since changed its name to National Alliance on Mental Illness. The group has and continues to rely upon pharmaceutical funding—-more than $41 million since 1996.

NAMI says it is a “grassroots mental health organization,” but falsely claims that 20% of the population are mentally ill.

NAMI’s campaign to “stop the stigma” and “end discrimination” against the mentally ill is really a pharmaceutical-funded front to sell harmful and addictive psychiatric drugs; the “Founding Sponsors” of the campaign were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.

You should know the chain of ownership that produced this NAMI PSA. Robin Meade is a news anchor at HLN TV, which is owned by CNN, which in turn is owned by WarnerMedia. The PSA was produced by WarnerMedia.

The whole purpose of this PSA, apparently, is to funnel people affected by the pandemic into the for-profit psychiatric mental health system.

The real NAMI encourages you to think you are mentally ill and relentlessly pushes psychiatric drugs and electroshock, gets millions from Pharma, and lobbies for Pharma’s vested interests. “Grassroots” indeed!

While these are definitely uncertain times, NAMI and the mental health industry are taking advantage of people’s fears and creating a market for dangerous psychotropic drugs in the midst of the Covid-19 crisis. One thing is certain — psychotropic drugs with their innumerable dangerous side effects are not the solution.

Take Action Now and Support CCHR.

Drinking too much coffee.

Individual Results May Vary

Monday, May 11th, 2020
We noticed that many pharmaceutical ads carry the phrase “individual results may vary”, or words to that effect. Since we are already skeptical about results claimed by psychiatric drug manufacturers and prescribers, we thought we’d investigate this more thoroughly.

The Federal Trade Commission (FTC) makes rules and recommendations about such claims in advertising. FTC 16 CFR 255Use of Endorsements and Testimonials in Advertising” is the reference. [CFR = Code of Federal Regulations]

The FTC calls an ad which touts the results of using a product an “endorsement.” It expects that any claims made for the product can be supported by a recognized expert in the field who has examined actual results for safety and efficacy.

The advertiser must either depict the generally expected consumer experience, or clearly and conspicuously disclose the typical experience a consumer can reasonably expect.

The use of the phrase “individual results may vary” is an attempt by the advertiser to “get off the hook” if the product does not produce the claimed results, and the FTC discourages the usage of this or similar qualifications.

Examining manufacturers’ fine print for their psychiatric drugs, we always see words to the effect that “we don’t really know how this drug works,” or “the exact mechanism of action is unknown.” Since they don’t know how the drug really “works”, there is no sure way to guarantee its safety and efficacy; they’re just guessing. Their “experts” then must of necessity use a “safe harbor” in their advertisements, since they cannot actually claim that the drugs work for everyone.

Of course, the drugs are just the tip of the deception. Psychiatrists must first make a diagnosis before they can prescribe a drug. The real problem, then, is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior or study problems as “diseases” or “mental disorders.”

Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful. The psychiatric billing bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM), is a fraudulent hoax designed to sell harmful and addictive drugs in order to keep vulnerable patients coming back for more treatments.

Contact your local, state and federal representatives and let them know what you think about this.
Results May Vary

Stigma

Wednesday, February 13th, 2013

What is a “stigma”?

A mark or characteristic indicative of a history of a disease or abnormality. [Middle English stigme, brand, from Latin stigma, stigmat-, tattoo indicating slave or criminal status, from Greek, tattoo mark, from stizein, stig-, to prick]

Is there a stigma associated with mental distress? First of all, the psychiatric manifestation known as “mental illness” is not a disease, it’s a symptom. And let’s face it, what a psychiatrist calls “abnormal” is just a label for something they don’t like.

Thomas Szasz proposed in 1960 that we view the phenomena conventionally called “mental diseases” as simply behaviors that disturb others (or oneself.)

So how do you fix disturbing behavior? Do you suppress it with drugs, involuntary commitment, restraints, surgery, or electric shock?

Or do you actually handle it by finding and treating the root cause, whatever that may be?

The campaign to “stop the stigma” of mental illness is a pharmaceutical marketing campaign.

With its seemingly altruistic sounding agenda to eliminate “stigma” the fact is the real “stigmatization” is coming from those behind this campaign — pharma, psychiatry and pharma-funded front groups such as NAMI and CHADD. For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill — the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.

The real stigmatization is coming from those that benefit from labeling behaviors as diseases to be “cured” or “treated” despite the complete lack of medical/biological evidence to support them.

Psychiatric labels are the stigma.

The forthcoming 2013 revision of the Diagnostic & Statistical Manual of Mental Disorders (DSM) will increase the number of people in the general population diagnosed with a mental illness — but what they need is help and understanding, not labels and medication.

Fraudulent diagnoses perpetrated by the DSM obscure the role of family, drug abuse, undiagnosed and untreated medical conditions, nutritional deficiencies, stress, illiteracy, and other factors contributing to mental distress. The result is often further stigma, discrimination and social exclusion.

What shall we do about this? How about labeling jars instead of people?

CCHR: Psychiatry Labeling Kids with
Bogus ‘Mental Disorders’

Watch the Video
****.
3992 ratings
726,680
views

Stop the Stigma: Buy More Psych Drugs?

Sunday, October 28th, 2012
Little known but Extremely Relevant Fact: The Campaign to “Stop the Stigma” of “Mental Illness” was launched by the Pharmaceutical Industry.

Lately we have been reading a deluge of news articles from all around the country about various campaigns to “stop the stigma of mental illness.” We wondered what all the fuss was about.

With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by those who benefit from more and more people being labeled mentally ill — pharma, psychiatry and pharmaceutical front groups such as NAMI and CHADD.

For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill — the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs. So next time you see an ad promoting “stop the stigma” see it for what it is, a pharmaceutical marketing campaign.

The majority of the public may or may not be familiar with these so-called mental health advocacy organizations, such as the National Alliance on Mental Illness (NAMI), Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD), or the myriad of bipolar, depression or ADHD “support groups” that are inundating the internet.

But they need to be.

ARE THESE SO-CALLED MENTAL HEALTH ADVOCACY GROUPS FOR PATIENT’S RIGHTS OR PHARMA’S RIGHTS? YOU DECIDE!

These are groups operating under the guise of advocates for the “mentally ill,” which in reality are heavily funded pharmaceutical front groups — lobbying and working on state and federal laws which effect the entire nation — from our elderly in nursing homes to our military, pregnant women, nursing mothers and school children.

Presenting themselves as patient advocacy groups is highly disingenuous not only to their membership, many of which may have a sincere desire to help a loved one or a family member with mental problems, but to legislators, the press and the American public — for they have consistently lobbied for legislation that benefits the mental health and pharmaceutical industries which fund them, and not patients they claim to represent.

Certainly any organization claiming to be for the rights of patients diagnosed mentally ill would have as their primary goal, full informed consent in the field of mental health — including full and complete disclosure of all drug risks, the right to refuse treatment, the right to know that psychiatric diagnoses are not medical conditions (evident by the fact there is not one confirmatory medical or scientific test). Above all such groups would provide patients with an abundance of information on non-harmful, non- drug, medical solutions and options considering the dangerous and well documented risks of psychiatric drugs by international drug regulatory agencies.

These groups do not.

To put it simply, these groups are not what they appear to be. Yet their influence over legislation, lobbying, drug regulation (or lack thereof), and public relations campaigns is substantial and effects the entire nation. For they claim to be the voice of the “mentally ill.” But are they? Or are they the result of a brilliant marketing/lobbying campaign designed to benefit the Psycho/Pharmaceutical industry that funds them?

Go here to read how all this started!

There are groups that are not funded by pharmaceutical companies, that truly do have the best interests of the consumer/patient and parent as their goal. You can find out more about such organizations here.

Do Something About It

Show a CCHR documentary DVD to all your family, friends, neighbors, and associates.

Psychiatry Stigmatizing Kids with Bogus Mental Disorders

Wednesday, December 29th, 2010

Click Here To Watch Our New Video:

Stigmatizing Kids